Cape Breton Capital raises C$1.2M second fund, backs four startups
What's the deal? Cape Breton Capital GroupDealroom has a profile for this one. Try Dealroom → has launched the Cape Breton Future FundDealroom has a profile for this one. Try Dealroom → (CBFF), a C$1.2 million angel investment fund targeting early-stage companies with ties to Cape Breton. It is the group's second fund and has already backed four companies.
Who's backing it? The fund draws on 22 angel investors, 11 of them new to Cape Breton Capital Group. They bring experience across entrepreneurship, technology, operations, finance, and sector-specific fields.
Where's the money going? The CBFF invests in small businesses registered in Nova Scotia with a meaningful connection to Cape Breton — through research and development, executive leadership, a headquarters, or local employment. Its four current holdings span cleantech and biotech: Aeon BlueDealroom has a profile for this one. Try Dealroom →, SEVO BiosciencesDealroom has a profile for this one. Try Dealroom →, BryoSphere BiotechnologiesDealroom has a profile for this one. Try Dealroom →, and alterBiotaDealroom has a profile for this one. Try Dealroom →.
Sydney-based Aeon Blue develops sustainable e-fuels while capturing carbon dioxide, and was named Startup Venture of the Year at the Canadian Cleantech Awards in May. SEVO Biosciences makes oral aquaculture vaccines using engineered microalgae, while BryoSphere manufactures skincare products from moss-derived compounds. Fellow Sydney firm alterBiota makes deltaC, a lower-carbon concrete additive built with biochar.
Why now? Managing director Paul Harrington credited Nova Scotia's Venture Capital Tax Credit with drawing private money. "The VCTC played a meaningful role in helping us attract investors and provide critical early support to startups through private investment," he said.
The fund extends the mandate of the group's first vehicle: supporting early-stage businesses rooted in Cape Breton as they build markets beyond the region.
What's next? Cape Breton Capital Group is already planning a third fund, this one focused on businesses connected to rural Nova Scotia.
The signal: A small angel fund pooling 22 backers points to how regional capital and tax incentives can keep early-stage cleantech and biotech anchored in Atlantic Canada rather than migrating to larger hubs.
Read more: entrevestor.com
Image credit: Generated with Gemini
